嘉实医药健康C(005304)
动态评分： 5.63分
投资组合
| 报告日期 | 代码 | 名称 | 金额（万元） | 比例 |
| 2023-06-30 | 019638 | 20国债09 | 2589.29 | 1.82% |
| 2023-06-30 | 019688 | 22国债23 | 1081.98 | 0.76% |
| 2023-03-31 | 230001 | 23附息国债01 | 5013.93 | 2.89% |
| 2023-03-31 | 019638 | 20国债09 | 2575.92 | 1.49% |
| 2023-03-31 | 019688 | 22国债23 | 1075.06 | 0.62% |
| 2022-12-31 | 200003 | 20附息国债03 | 5092.67 | 2.99% |
| 2022-12-31 | 019638 | 20国债09 | 2208.19 | 1.3% |
| 2022-09-30 | 200003 | 20附息国债03 | 5073.94 | 3.22% |
| 2022-09-30 | 019638 | 20国债09 | 474.46 | 0.3% |
| 2022-06-30 | 229902 | 22贴现国债02 | 4994.91 | 3.08% |
| 2022-06-30 | 118006 | 阿拉转债 | 360.91 | 0.22% |
| 2022-03-31 | 229902 | 22贴现国债02 | 4969.14 | 3.5% |
| 2022-03-31 | 118006 | 阿拉转债 | 194.43 | 0.14% |
| 2021-12-31 | 210201 | 21国开01 | 5001.5 | 3.18% |
| 2021-09-30 | 210201 | 21国开01 | 5003 | 3.02% |
| 2021-06-30 | 210201 | 21国开01 | 5003 | 2.75% |
| 2021-03-31 | 210201 | 21国开01 | 4991 | 3.29% |
| 2020-12-31 | 180203 | 18国开03 | 5021 | 2.79% |
| 2020-09-30 | 180203 | 18国开03 | 5039 | 2.61% |
| 2020-06-30 | 180203 | 18国开03 | 5082 | 2.68% |
公告&资料
